Organogenesis Holdings Inc. Announces Board and Executive Changes
Ticker: ORGO · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1661181
| Field | Detail |
|---|---|
| Company | Organogenesis Holdings INC. (ORGO) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, corporate-governance
Related Tickers: ORGO
TL;DR
Organogenesis (ORGO) board shakeup and exec comp changes filed today.
AI Summary
Organogenesis Holdings Inc. announced on June 23, 2025, changes related to its board of directors and executive compensation. The filing indicates a departure of a director, the election of a new director, and updates to compensatory arrangements for certain officers. Additionally, the company submitted matters to a vote of its security holders.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directorship and executive compensation can indicate internal shifts that may affect company strategy and performance.
Key Players & Entities
- Organogenesis Holdings Inc. (company) — Registrant
- June 23, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 001-37906 (identifier) — Commission File Number
- 85 Dan Road Canton, MA 02021 (address) — Principal executive offices
- (781) 575-0775 (phone_number) — Registrant's telephone number
FAQ
What specific changes were made to the board of directors?
The filing indicates the departure of a director and the election of a new director, though their names are not specified in this summary.
What is the nature of the updates to executive compensation?
The filing mentions updates to 'Compensatory Arrangements of Certain Officers' but does not provide specific details on the nature of these changes.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the specific proposals are not detailed in this summary.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 23, 2025.
What is Organogenesis Holdings Inc.'s principal executive office address?
Organogenesis Holdings Inc.'s principal executive office is located at 85 Dan Road Canton, MA 02021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Organogenesis Holdings Inc. (ORGO).